Phenex Pharmaceuticals Report issue

For profit Phase 2
Founded: Ludwigshafen Am Rhein-oggersheim Germany (2002)
Status: Acquired by Gilead Sciences (2015)

Organization Overview

First Clinical Trial
2011
NCT01998659
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Phenex Pharmaceuticals AG

Active Ingredients

Drugs in Phase 2 Trials (1)

px-104 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatty Liver (Phase 2)

Liver Diseases (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1